Skip to content
Review Open access

Developing a FAIR data policy for chemical risk assessment and exploring future topics and stakeholder interests with large language models and data sciences

Jul 2026 · Environmental Sciences Europe · 0 citations

TL;DR

The PFDP is designed to support data driven RA improvement within PARC but can equally contribute to FAIR data in other environmental RA research and regulatory communities.

Abstract

The EU Partnership for the Assessment of Risk from Chemicals (PARC) develops novel methods for human health and environmental risk assessment (RA) for regulatory application. Large amounts of environmental monitoring, in vitro, in silico and other types of data are generated. To facilitate data reuse and information exchange within and between research and regulatory stakeholders, it is important to document and manage data. In 2016, the FAIR (Findable, Accessible, Interoperable and Reusable) data principles were introduced to foster reuse of data. To adopt FAIR within PARC, a PARC FAIR data policy (PFDP) was developed. To determine PFDP topics, expert panel discussions were held, followed by review of 37 stakeholder documents issued by authorities in RA and environmental, health, (open) data sciences. This resulted in a taxonomy of 57 topics (“narrower term(s)” (NT(s), together with 15 “broader terms”), forming the basis of the PFDP. These included, aside FAIR, aspects specifically relevant for RA, such as GDPR, sensitive data, transparency and data valuation. Large Language Models (LLMs) were used to contrive novel terms for PFDP revisions. Seventy-eight novel terms were discovered by LLMs, compared to 57 NTs already identified by experts. Based on a frequency analysis within stakeholder documents, of all 135 terms (57 + 78) -further categorized under eight ChatGPT-derived “FAIR categories”- and subsequent cluster analyses (PCA, K-means), differences between stakeholders were identified. Organizations concerned with environmental and human chemical RA (e.g. European Chemicals Agency, European Food Safety Authority) could be distinguished from those focused on technical FAIR data issues and those involved in publicly funded research and open science. To foster environmental and human health research data for research purposes and adoption of research data in regulatory applications, a taxonomy of terms and FAIR data policy was developed. A frequency analysis of the taxonomy (augmented with LLM-derived) terms in stakeholder documents revealed differences between stakeholders, which may help identify trends e.g. the adoption of FAIR principles within and across sciences and regulatory domains for (NG) RA. The PFDP is designed to support data driven RA improvement within PARC but can equally contribute to FAIR data in other environmental RA research and regulatory communities.

Read PDF

Similar papers

Review Open access Aug 2026

PFAS: challenges and scientific perspectives in human health risk assessment.

Five key recommendations for future health risk assessments are concluded, prioritizing PFAS; improving analytical methods; promoting generation of robust data and data gap filling; promoting open science, including the development of shared data infrastructure and cross-institutional knowledge exchange; and strengthen...

J. Kowalczyk, Klaus Abraham, Christina August et al. · 0 citations
Open access Aug 2026

Update of the 2025 and 2026 standard regulatory actions for prospective and retrospective cumulative dietary risk assessment of pesticides in MCRA

Abstract Regulatory concern over human exposure to chemical mixtures has intensified, as individuals are continuously exposed to multiple chemical substances from various sources. Historically, the European Food Safety Authority (EFSA) assesses risks based on individual chemicals or expected co‐occurring groups of chem...

M. Schepens, J. Kruisselbrink, G. van Donkersgoed et al. · 0 citations
Review Open access Aug 2026

An evaluation of the use of the Universal Benefit-Risk Assessment Framework by the Zambia Medicines Regulatory Authority for documenting and communicating benefit-risk decisions.

Transparent and consistent medicines approval processes support stakeholder trust in National Medicines Regulatory Authorities (NMRAs). Structured benefit-risk assessment frameworks may strengthen such transparency and consistency. One example is the Universal Methodology for Benefit-Risk Assessment (UMBRA) developed b...

Constance Sakala Chisha, Stephanie Leigh, Prudence Musonda Mubanga et al. · 0 citations
Sep 2026

Improving consistency in regulatory assessment of repeated-dose toxicity studies: an EFSA checklist-based framework for statistical evaluation.

The evaluation of 28- and 90-day repeated-dose toxicity studies in rodents is typically performed at the highest tier of regulatory toxicology. Despite detailed guidance from the European Food Safety Authority (EFSA) and Organisation for Economic Co-operation and Development (OECD), the practical implementation and eva...

S. Favilla, Eugenio Traini, M. Ardizzone et al. · 0 citations
Aug 2026

Supporting Integrated Chemical Risk Management: Aligning Safe and Sustainable by Design and EU Ecolabel Decision Frameworks.

The increasing proliferation of policy-driven frameworks addressing chemical safety and sustainability has intensified the need for coherence and integration in environmental assessment and management. In the European context, Safe and Sustainable by Design (SSbD) and the EU Ecolabel represent influential but conceptua...

Arthur Ribas de Souza Sales · 0 citations
Review Open access Aug 2026

Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance

Regulatory bodies play a central role in providing guidance that enables safe and effective use of artificial intelligence tools in medicine development and evaluation. Regulators can also act as catalysts for regulatory science research. To inform these efforts, a European‐wide survey was conducted to solicit stakehol...

Luis C. Pinheiro, Amanda C Langston, M. Orre et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.